Lupus Biomarkers

Therapeutics, Biologics, Biomarkers, and Diagnostics

Clinician:  Mary Crow, MD
Developer:  Mikhail Olferiev, MD

Through a comprehensive molecular analysis of several cohorts of lupus patients, biomarkers were identified that link heterogeneous clinical features of lupus to specific molecular mechanisms which will aid in stratifying patients for treatment and providing potential new therapeutic targets for treating the disease.

Legal Status: Patent Pending (US 2014/0135225)

If you have questions about this technology, please contact